| http://dbpedia.org/ontology/abstract
|
The Combating Antibiotic Resistant Bacteri … The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global nonprofit partnership focused on supporting antibacterial research. Its mission is to strengthen the pipeline of therapeutics, diagnostics and preventatives to diagnose and treat life-threatening bacterial infections. CARB-X was launched in summer of 2016 at the Boston University School of Law, where CARB-X Executive Director Professor Kevin Outterson teaches health law, corporate law, and co-directs the Health Law Program. In its first five years, from 2016 to 2021, CARB-X awarded $361 million to 92 projects. In 2022, BARDA and Wellcome renewed committed renewed funding up to an additional $370 million to CARB-X. In addition to awarding non-dilutive funding, CARB-X partners with a Global Accelerator Network (GAN) of experts who offer product developers advice on a range of issues, including drug development, business strategy, policy and regulatory affairs.s strategy, policy and regulatory affairs.
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://carb-x.org/ +
, https://www.gov.uk/government/groups/the-global-amr-innovation-fund +
, https://fundit.fr/en/institutions/german-federal-ministry-education-and-research-bmbf +
|
| http://dbpedia.org/ontology/wikiPageID
|
53474837
|
| http://dbpedia.org/ontology/wikiPageLength
|
7012
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123408547
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Funding_bodies +
, http://dbpedia.org/resource/Bill_&_Melinda_Gates_Foundation +
, http://dbpedia.org/resource/National_Institute_of_Allergy_and_Infectious_Diseases +
, http://dbpedia.org/resource/Office_of_the_Assistant_Secretary_for_Preparedness_and_Response +
, http://dbpedia.org/resource/Category:Partnerships +
, http://dbpedia.org/resource/Wellcome_Trust +
, http://dbpedia.org/resource/National_Institutes_of_Health +
, http://dbpedia.org/resource/Biomedical_Advanced_Research_and_Development_Authority +
, http://dbpedia.org/resource/Category:Antimicrobial_resistance_organizations +
, http://dbpedia.org/resource/Boston_University_School_of_Law +
, http://dbpedia.org/resource/Kevin_Outterson +
, http://dbpedia.org/resource/Category:Non-profit_corporations +
, http://dbpedia.org/resource/Category:Boston_University_School_of_Law +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Nonprofit-org-stub +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Funding_bodies +
, http://dbpedia.org/resource/Category:Non-profit_corporations +
, http://dbpedia.org/resource/Category:Boston_University_School_of_Law +
, http://dbpedia.org/resource/Category:Partnerships +
, http://dbpedia.org/resource/Category:Antimicrobial_resistance_organizations +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/CARB-X?oldid=1123408547&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/CARB-X +
|
| owl:sameAs |
https://global.dbpedia.org/id/FnZJz +
, http://dbpedia.org/resource/CARB-X +
, http://www.wikidata.org/entity/Q107298395 +
|
| rdfs:comment |
The Combating Antibiotic Resistant Bacteri … The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global nonprofit partnership focused on supporting antibacterial research. Its mission is to strengthen the pipeline of therapeutics, diagnostics and preventatives to diagnose and treat life-threatening bacterial infections. CARB-X was launched in summer of 2016 at the Boston University School of Law, where CARB-X Executive Director Professor Kevin Outterson teaches health law, corporate law, and co-directs the Health Law Program.aw, and co-directs the Health Law Program.
|
| rdfs:label |
CARB-X
|
